One possible explanation for the low recorded testosterone and PSA measurements in the study population is that data from CPRD is limited to primary care, and that these data are only available in secondary care electronic health records where prostate cancer is typically diagnosed and managed. Here, KLK3 is linked to prostate carcinoma.